CVA Stroke

Printing and PDF export are disabled for this protected preview. Continue reading inside the DiraChart reader.

Trace DC84-3

DiraChart Clinical Reference
Protected section 3 of 15
← Document menu
Nursing Home · DiraChart

1. Purpose and clinical relevance

DiraChart Clinical Reference

Section NavigationPart 3 of 15PreviousNext

2. What to assess, technique, and required data

Document the stroke-specific skilled rehabilitation and surveillance each day:

  • The deficit set and its trajectory (motor strength, sensation, swallowing, communication, cognition, vision), the therapy carryover, and function (Section GG usual performance).
  • Secondary-prevention parameters: blood pressure against the ordered goal, the antithrombotic regimen (antiplatelet or anticoagulation) and bleeding surveillance, and glucose where relevant.
  • Complication surveillance: aspiration signs (route to Taste/Swallowing), DVT signs, post-stroke mood, and — critically — any new or worsening deficit signaling a recurrent stroke.

MDS-supportive data

Function is coded in MDS Section GG, cognition in Section C, speech/vision in Section B, therapy in Section O, antithrombotic medications in Section N, and stroke in Section I. The record must document the deficit trajectory, the rehabilitation nursing, secondary prevention, and complication surveillance so the MDS is supported.

Section NavigationPart 3 of 15PreviousNext